Research Progress on Immune Checkpoint Inhibitors in Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death, and most patients with HCC are diagnosed at an advanced stage. Before 2017, tyrosine kinase inhibitors were the main drugs for the treatment of advanced hepatocellular carcinoma. With the emergence of immune che...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Chinês |
| Izdano: |
Magazine House of Cancer Research on Prevention and Treatment
2023-05-01
|
| Serija: | Zhongliu Fangzhi Yanjiu |
| Teme: | |
| Online dostop: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1325 |
| Oznake: |
Brez oznak, prvi označite!
|